• Medpace Holdings President and CEO August J. Troendle sold 48,667 common shares on Sept. 29-30.
• Sales priced at USD 621.02 per share on Sept. 29, USD 625.47 per share on Sept. 30.
• Directly held stake fell to 338,225 shares following the transactions.
• Troendle also reported 4,733,019 shares held indirectly through Medpace Investors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001622058-26-000022), on October 01, 2026, and is solely responsible for the information contained therein.